Peripheral vascular disease and type 2 diabetes mellitus (Q34071984)

30 July 2017

1 reference

title

Peripheral vascular disease and type 2 diabetes mellitus (English)

1 reference

30 July 2017

0 references

1 reference

Schaper NC

1

1 reference

PubMed ID

11054881

30 July 2017

Nabuurs-Franssen MH

series ordinal

2

1 reference

PubMed ID

11054881

30 July 2017

Huijberts MS

series ordinal

3

1 reference

30 July 2017

1 September 2000

1 reference

Diabetes - Metabolism: Research and Reviews

30 July 2017

1 reference

30 July 2017

16 Suppl 1

1 reference

30 July 2017

S11-5

1 reference

Course of peripheral occlusive arterial disease in diabetes. Vascular laboratory assessment

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Progression of Lower-Extremity Arterial Occlusive Disease in Type II Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

The relationship between cow's milk exposure and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Insulin resistance and arteriosclerosis obliterans in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Endothelial function in health and disease: new insights into the genesis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Nitric oxide and vascular responses in Type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Hyperglycemia and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Regional heterogeneity of arterial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

High-fat meals and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

Effect of diabetes mellitus on formation of coronary collateral vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR112%3E3.0.CO%3B2-V

10.1002/1520-7560(200009/10)16:1+<::AID-DMRR112>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11054881